Screener
Jade Biosciences JBIO Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Jade Biosciences’s reported figures.
Based on the most recent quarter.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
FAQ
- What is Jade Biosciences's debt-to-equity?
- Jade Biosciences (JBIO) reported debt-to-equity of 0× in Q1 2026.
- What is the long-term trend for Jade Biosciences's debt-to-equity?
- Over 3 years (2021 to 2025), Jade Biosciences's debt-to-equity has grown at a -7.6% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Jade Biosciences's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude